Summary GLP-1 agonists not only help reduce plasma glucose levels in type-2 diabetics, but also help improve markers of cardiovascular function including blood pressure, cholesterol, and weight loss
10.1016/j.ccell.2025.05.011 Cancer Cell
Development of an adverse outcome pathway from drug-mediated bile salt export pump inhibition to cholestatic liver injury
Depths above that increase risk of scarring and infection without professional training and sterile technique
Las complicaciones relacionadas con la obesidad son numerosas e incluyen diabetes tipo 2, enfermedad renal crnica, enfermedad de hgado graso no alcohlica, cncer y un mayor riesgo de enfermedades cardiovasculares, incluyendo ataque cardaco y accidente cerebrovascular, niveles altos de azcar en la sangre, colesterol, presin arterial e inflamacin